![Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21168-6/MediaObjects/41467_2021_21168_Fig1_HTML.png)
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
![A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/44b75185-125a-43b2-b93d-b49a475df337/eji3979-fig-0002-m.jpg)
A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library
![Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity](https://pub.mdpi-res.com/cancers/cancers-13-01401/article_deploy/html/images/cancers-13-01401-g001.png?1616467447)
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
![Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy | Journal for ImmunoTherapy of Cancer Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/8/2/e001150/F5.large.jpg)
Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy | Journal for ImmunoTherapy of Cancer
![General Lymphocyte Marker Antibody Panel (CD3, CD14, CD16, CD19, CD56) (ARG30313) - arigo Biolaboratories General Lymphocyte Marker Antibody Panel (CD3, CD14, CD16, CD19, CD56) (ARG30313) - arigo Biolaboratories](https://www.arigobio.com/files/product/2312/MEM-154_1.jpg)
General Lymphocyte Marker Antibody Panel (CD3, CD14, CD16, CD19, CD56) (ARG30313) - arigo Biolaboratories
![Flow cytometry analysis of B-cell antigenic surface markers B220 and... | Download Scientific Diagram Flow cytometry analysis of B-cell antigenic surface markers B220 and... | Download Scientific Diagram](https://www.researchgate.net/publication/8060963/figure/fig1/AS:278600059244554@1443434838730/Flow-cytometry-analysis-of-B-cell-antigenic-surface-markers-B220-and-CD19-in-FL-at-days.png)
Flow cytometry analysis of B-cell antigenic surface markers B220 and... | Download Scientific Diagram
![Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells - ScienceDirect Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124715011122-fx1.jpg)